CW November 2003

category image Volume 12
Issue Number 11
November 2003
ISSN 10593802

Circadian Clock Genes may Provide Targets for Cancer Drugs

Circadian rhythmicity in mammals is a complex phenomenon and is under the control of a molecular pacemaker consisting of clock gene products organized in autoregulatory loops. Clock genes are found to coordinate many basic functions such as cell proliferation and apoptosis. Cancer cells and normal cells are also thought to follow different circadian rhythms. The rhythmical expression of certain key regulatory proteins in cancer cells can be used to target cancer drugs.
Go to Previous Page
Go to Next Page

Source & Additional Reading

S. You et al., American Association of Cancer Research held in Boston, MA, November 17-21, 2003.
L. Fu et al., American Association of Cancer Research held in Boston, MA, November 17-21, 2003.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW November 2003

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login